In addition, 18F-FMISO PET imaging was also applied in preclinical models of breast and colon cancer to probe the tumor and its surrounding microenvironment before and during PD-1 and CTLA-4 checkpoint blockade to quantify tumor hypoxia. This evidence concerns the gene CTLA4 and colonic neoplasm.